Please enable JavaScript to continue using this application.

Compare $ARDX vs $ODTX | Chartloom

Compare

$ARDX vs $ODTX

Ardelyx Inc · Odyssey Therapeutics Inc

ARDX

Ardelyx Inc

ODTX

Odyssey Therapeutics Inc

Compare $ARDX vs $ODTX

Comparing Ardelyx Inc and Odyssey Therapeutics Inc

ARDXArdelyx Inc

ODTXOdyssey Therapeutics Inc

ARDXArdelyx Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

688.58x

Forward P/S (NTM)

1.51x

Rev growth (TTM)

16.8%

YTD performance

-46.7%

52W performance

-35.2%

FCF yield

-2.2%

ODTXOdyssey Therapeutics Inc

Market cap

$913M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.0%

YTD performance

15.7%

52W performance

15.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARDX

ODTX

Detailed metrics comparison

ARDX

Ardelyx Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

ARDX$810M

ODTX$913M

Enterprise Value

ARDX$965M

ODTX$831M

Price

ARDX$3.28

ODTX$19.00

P/E Ratio

ARDXN/A

ODTXN/A

P/S Ratio

ARDX1.80x

ODTX306.64x

EV/Sales

ARDX2.14x

ODTX279.08x

EV/EBITDA

ARDX454.80x

ODTX0.00x

P/B Ratio

ARDX5.59x

ODTX2.36x

P/FCF Ratio

ARDXN/A

ODTXN/A

EV/FCF

ARDX-53.85x

ODTX-21.89x

PEG Ratio

ARDXN/A

ODTXN/A

Forward P/E (NTM)

ARDX688.58x

ODTXN/A

Forward P/S (NTM)

ARDX1.51x

ODTXN/A

Revenue (TTM)

ARDX$451M

ODTX$3M

Revenue Growth (YoY)

ARDX16.8%

ODTX-19.0%

Forward Rev Growth

ARDX27.5%

ODTX410.3%

Gross Margin (TTM)

ARDX94.4%

ODTX0.0%

Operating Margin (TTM)

ARDX0.0%

ODTX0.0%

EBITDA Margin (TTM)

ARDX-7.1%

ODTX-3193.4%

Net Margin (TTM)

ARDX-12.4%

ODTX-8054.3%

FCF Margin (TTM)

ARDX-4.0%

ODTX-1275.0%

Net Income (TTM)

ARDX$-56M

ODTX$-240M

FCF (TTM)

ARDX$-18M

ODTX$-38M

EPS (TTM)

ARDX-$0.22

ODTX-$7.92

ROE (TTM)

ARDX-3600.0%

ODTX-3030.0%

ROA (TTM)

ARDX-1077.0%

ODTX-2554.0%

ROIC (TTM)

ARDX-1506.0%

ODTX-3030.0%

Cash

ARDX$97M

ODTX$82M

Debt

ARDX$252M

ODTX$0

Net Cash/Debt

ARDX$-155M

ODTX$82M

Current Ratio (TTM)

ARDX3.34x

ODTX11.36x

Quick Ratio (TTM)

ARDX2.89x

ODTX10.98x

Debt/Equity (TTM)

ARDX1.69x

ODTX0.00x

Debt/Assets (TTM)

ARDX0.0%

ODTX0.0%

Interest Coverage (TTM)

ARDXN/A

ODTXN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

ODTX0.00x

Beta

ARDX0.72

ODTX-0.23

52W Performance

ARDX-35.2%

ODTX15.7%

YTD Performance

ARDX-46.7%

ODTX15.7%

% from 52W High

ARDX-61.0%

ODTX-34.6%

% from 52W Low

ARDX3.1%

ODTX25.8%

Asset Turnover (TTM)

ARDX0.87x

ODTX0.00x

FCF Yield (TTM)

ARDX-2.2%

ODTX-4.2%

Earnings Yield (TTM)

ARDX-6.9%

ODTX-26.3%

Dividend Yield (TTM)

ARDXN/A

ODTXN/A

Rule of 40

ARDX12.8

ODTX-1,294.1

EV/GP/RG

ARDX0.10

ODTXN/A

Ticker research

View ARDX research View ODTX research

Metric	ARDX Ardelyx Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$810M	$913M
Enterprise Value	$965M	$831M
Price	$3.28	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	306.64x
EV/Sales	2.14x	279.08x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$3M
Revenue Growth (YoY)	16.8%	-19.0%
Forward Rev Growth	27.5%	410.3%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	-3193.4%
Net Margin (TTM)	-12.4%	-8054.3%
FCF Margin (TTM)	-4.0%	-1275.0%
Net Income (TTM)	$-56M	$-240M
FCF (TTM)	$-18M	$-38M
EPS (TTM)	-$0.22	-$7.92
ROE (TTM)	-3600.0%	-3030.0%
ROA (TTM)	-1077.0%	-2554.0%
ROIC (TTM)	-1506.0%	-3030.0%
Financial Health
Cash	$97M	$82M
Debt	$252M	$0
Net Cash/Debt	$-155M	$82M
Current Ratio (TTM)	3.34x	11.36x
Quick Ratio (TTM)	2.89x	10.98x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	-0.23
52W Performance	-35.2%	15.7%
YTD Performance	-46.7%	15.7%
% from 52W High	-61.0%	-34.6%
% from 52W Low	3.1%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-4.2%
Earnings Yield (TTM)	-6.9%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	-1,294.1
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View ODTX research

Valuation

P/S Ratio

ARDX

1.80x

ODTX

306.64x

EV/FCF

ARDX

-53.85x

ODTX

-21.89x

Growth & revenue

Revenue Growth TTM

ARDX

16.8%

ODTX

-19.0%

Forward Revenue Growth

ODTX

410.3%

ARDX

27.5%

Profitability & performance

Gross Margin

ARDX

94.4%

ODTX

0.0%

ROE

ODTX

-3030.0%

ARDX

-3600.0%

FCF Yield %

ARDX

-2.2%

ODTX

-4.2%

52-Week Performance

ODTX

15.7%

ARDX

-35.2%

Detailed metrics comparison

ARDX

Ardelyx Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

ARDX$810M

ODTX$913M

Enterprise Value

ARDX$965M

ODTX$831M

Price

ARDX$3.28

ODTX$19.00

P/E Ratio

ARDXN/A

ODTXN/A

P/S Ratio

ARDX1.80x

ODTX306.64x

EV/Sales

ARDX2.14x

ODTX279.08x

EV/EBITDA

ARDX454.80x

ODTX0.00x

P/B Ratio

ARDX5.59x

ODTX2.36x

P/FCF Ratio

ARDXN/A

ODTXN/A

EV/FCF

ARDX-53.85x

ODTX-21.89x

PEG Ratio

ARDXN/A

ODTXN/A

Forward P/E (NTM)

ARDX688.58x

ODTXN/A

Forward P/S (NTM)

ARDX1.51x

ODTXN/A

Revenue (TTM)

ARDX$451M

ODTX$3M

Revenue Growth (YoY)

ARDX16.8%

ODTX-19.0%

Forward Rev Growth

ARDX27.5%

ODTX410.3%

Gross Margin (TTM)

ARDX94.4%

ODTX0.0%

Operating Margin (TTM)

ARDX0.0%

ODTX0.0%

EBITDA Margin (TTM)

ARDX-7.1%

ODTX-3193.4%

Net Margin (TTM)

ARDX-12.4%

ODTX-8054.3%

FCF Margin (TTM)

ARDX-4.0%

ODTX-1275.0%

Net Income (TTM)

ARDX$-56M

ODTX$-240M

FCF (TTM)

ARDX$-18M

ODTX$-38M

EPS (TTM)

ARDX-$0.22

ODTX-$7.92

ROE (TTM)

ARDX-3600.0%

ODTX-3030.0%

ROA (TTM)

ARDX-1077.0%

ODTX-2554.0%

ROIC (TTM)

ARDX-1506.0%

ODTX-3030.0%

Cash

ARDX$97M

ODTX$82M

Debt

ARDX$252M

ODTX$0

Net Cash/Debt

ARDX$-155M

ODTX$82M

Current Ratio (TTM)

ARDX3.34x

ODTX11.36x

Quick Ratio (TTM)

ARDX2.89x

ODTX10.98x

Debt/Equity (TTM)

ARDX1.69x

ODTX0.00x

Debt/Assets (TTM)

ARDX0.0%

ODTX0.0%

Interest Coverage (TTM)

ARDXN/A

ODTXN/A

Net Debt/EBITDA (TTM)

ARDX0.00x

ODTX0.00x

Beta

ARDX0.72

ODTX-0.23

52W Performance

ARDX-35.2%

ODTX15.7%

YTD Performance

ARDX-46.7%

ODTX15.7%

% from 52W High

ARDX-61.0%

ODTX-34.6%

% from 52W Low

ARDX3.1%

ODTX25.8%

Asset Turnover (TTM)

ARDX0.87x

ODTX0.00x

FCF Yield (TTM)

ARDX-2.2%

ODTX-4.2%

Earnings Yield (TTM)

ARDX-6.9%

ODTX-26.3%

Dividend Yield (TTM)

ARDXN/A

ODTXN/A

Rule of 40

ARDX12.8

ODTX-1,294.1

EV/GP/RG

ARDX0.10

ODTXN/A

Ticker research

View ARDX research View ODTX research

Metric	ARDX Ardelyx Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$810M	$913M
Enterprise Value	$965M	$831M
Price	$3.28	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	1.80x	306.64x
EV/Sales	2.14x	279.08x
EV/EBITDA	454.80x	0.00x
P/B Ratio	5.59x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-53.85x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	688.58x	N/A
Forward P/S (NTM)	1.51x	N/A
Revenue & Growth
Revenue (TTM)	$451M	$3M
Revenue Growth (YoY)	16.8%	-19.0%
Forward Rev Growth	27.5%	410.3%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.1%	-3193.4%
Net Margin (TTM)	-12.4%	-8054.3%
FCF Margin (TTM)	-4.0%	-1275.0%
Net Income (TTM)	$-56M	$-240M
FCF (TTM)	$-18M	$-38M
EPS (TTM)	-$0.22	-$7.92
ROE (TTM)	-3600.0%	-3030.0%
ROA (TTM)	-1077.0%	-2554.0%
ROIC (TTM)	-1506.0%	-3030.0%
Financial Health
Cash	$97M	$82M
Debt	$252M	$0
Net Cash/Debt	$-155M	$82M
Current Ratio (TTM)	3.34x	11.36x
Quick Ratio (TTM)	2.89x	10.98x
Debt/Equity (TTM)	1.69x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.72	-0.23
52W Performance	-35.2%	15.7%
YTD Performance	-46.7%	15.7%
% from 52W High	-61.0%	-34.6%
% from 52W Low	3.1%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-2.2%	-4.2%
Earnings Yield (TTM)	-6.9%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	12.8	-1,294.1
EV/GP/RG	0.10	N/A
Ticker research	View ARDX research	View ODTX research